Donna Pepin
Donna Pepin
The 3CTN EDI Framework and Toolkit is Launched
The Canadian Cancer Clinical Trials Network (3CTN) and its collaborative partners are thrilled to announce the launch of an Equity, Diversity, and Inclusion (EDI) Framework and companion Toolkit designed to support the Canadian research community in embedding EDI best practices within clinical tri... Read More »
The Canadian Cancer Clinical Trials Network (3CTN) and its collaborative partners are thrilled to announce the launch of an Equity, Diversity, and Inclusion (EDI) Framework and companion Toolkit designed to support the Canadian research community in embedding EDI best practices within clinical tri... Read More »
Learn what CanPath has to offer researchers
Are you conducting cancer, chronic disease or COVID-19 research?
The Canadian Partnership for Tomorrow’s Health, CanPath, is Canada’s largest population health study. CanPath recently released their latest video, Read More »
Are you conducting cancer, chronic disease or COVID-19 research?
The Canadian Partnership for Tomorrow’s Health, CanPath, is Canada’s largest population health study. CanPath recently released their latest video, Read More »